Genomic insights into uterine leiomyosarcoma: Unraveling KMT2D, CREBBP, NOTCH2, TSC2, ATM, and GNAS signatures. [PDF]
Dos Anjos LG +5 more
europepmc +1 more source
Rannsókn á microRNA stýringu á KMT2D í Kabuki heilkenni 1
Kabuki heilkenni (KH) er sjaldgæfur sjúkdómur tengdur utangenaerfðakerfinu sem fellur í hóp MDEM sjúkdóma (Mendelian disorders of the epigenetic machinery). Svo hefur verið metið að einn af hverjum 32,000 séu með KH.
Jóhann Örn Thorarensen 1997-
core
Mouse models of B cell lymphomas on the basis of genetic features. [PDF]
Yuan M, Wang JQ.
europepmc +1 more source
Low-grade osteogenic tumor with secondary aneurysmal bone cyst: Distinguishing osteoblastoma from low-grade osteosarcoma in the setting of noncanonical molecular findings. [PDF]
Shabbir-Hussain R +5 more
europepmc +1 more source
Targeting CCR7-KMT2D enhances CAR-T cell efficacy by suppressing therapy-induced senescence in B-cell non-Hodgkin lymphoma. [PDF]
Li J +16 more
europepmc +1 more source
Age-Specific Transcriptomic Signatures for Classification of Progression-Free Survival Outcomes in Luminal A Breast Cancer: An Integrative Machine Learning Approach. [PDF]
Kivrak M, Nalkiran I, Sevim Nalkiran H.
europepmc +1 more source
Kabuki syndrome (KS) is a rare, multi-systemic congenital disorder caused by mutations in histone N-methyltransferase 2D (KMT2D), a histone methyltransferase that regulates histone 3 lysine 4 mono-methylation (H3K4me1), a key epigenetic mark associated ...
Kwak, Jooyeong
core
Loss of Kmt2c/d promotes gastric cancer and confers vulnerability to mTORC1 and PD-1 inhibition. [PDF]
Wang N +13 more
europepmc +1 more source
Congenital Type III Lip Sinus with Palatine Bone Cleft. [PDF]
Kumari R +6 more
europepmc +1 more source

